Koneksa contributed to the new Digital Medicine Society (DiMe) V3+ framework, which adds usability to the process of validating digital health technologies (DHTs). Usability is an important aspect of successful…
Read More
NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, today announced the publication of a new multi-domain model for capturing functional status in oncology through connected digital tools...
Read More
If you’re reading this, it’s overwhelmingly likely that you have a smartphone, and possibly a fitness tracker. Digital Health Technologies (DHTs) like these can help us learn more about our…
Koneksa was privileged recently to present at the annual meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) alongside colleagues from the U.S. Food & Drug Administration (FDA)…
Recently, the FDA released draft guidance for comment on remote digital data acquisition in clinical trials. The applications of digital health technologies (DHT) in clinical trials gained traction over the…
The digital field has been greatly transformed during the 18 months of the pandemic. The timid pre-pandemic attempts to test and explore digital health technologies (DHT) were swiftly replaced by…
